Semaglutide is a medication that belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) agonists. It is used to treat type 2 diabetes and obesity.

Semaglutide works by mimicking the effects of GLP-1 in the body. It stimulates the production and release of insulin and inhibits the production of glucagon, helping to lower blood sugar levels in people with type 2 diabetes. Semaglutide may also help to reduce food intake and promote weight loss in people who are obese.

The amount of weight lost may vary depending on various factors, but many clients experience a loss of about 5% of their initial body weight. Over the course of 12 weeks, this loss can increase to as much as 10%, resulting in a weight loss of 10-20 pounds for a person who weighs 200 pounds. However, it is important to note that individual results may vary and the most successful patients typically make diet and lifestyle changes to support their weight loss journey. For more information, please visit: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209637lbl.pdf

Semaglutide is typically taken once weekly as a subcutaneous injection. It is important to follow the dosing instructions provided by our healthcare providers and to monitor blood sugar levels regularly while using this medication.